U.S. central venous catheter, or a central line, is a thin, flexible tube that is inserted into a vein and guided (threaded) into a large vein towards the heart known as superior vena cava for easy administration of blood products, intravenous fluids, chemotherapy, parenteral nutrition, drugs, as well as to offer hemodialysis access and hemodynamic monitoring. These medical devices are used for long-term treatment in various diseases such as end-stage kidney disease (dialysis) and cancer (chemotherapy), among others.
U.S. central venous catheters are of three types, such as a tunnelled central venous catheter, a subcutaneous (implanted) port, and a peripherally inserted central catheter (PICC). Doctors will recommend the type of central venous catheter one should have based on their situation and how long the central venous catheter may be needed. Central venous catheter is necessary when someone needs medicine given through their veins for a long time, or when they need kidney dialysis. Moreover, they are used to measure central venous pressure (CVP).
“According to Coherent Market Insights, The U.S. central venous catheter market is expected to witness significant growth due to increasing adoption of collaboration strategies by market players. For instance, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new health care industry leader with approximately US$ 16 billion in annualized revenue. Similarly, in July 2018, B.Braun Melsungen AG acquired the bloodlines business of NxStage Medical, Inc. This acquisition helped the dialysis business of B. Braun Melsungen AG.”
Doctors may place a central line for someone who needs IV nutrition, has cancer so they can get chemotherapy, and has a serious infection so they can get IV antibiotics for a few weeks, as well as for hemodialysis. Thus, with the increasing prevalence of cancer and renal diseases across the world, the demand for central venous catheters is also increasing at a rapid pace. For example, according to the American Cancer Society, in 2021, an estimated 1.9 million new cancer cases will be diagnosed in the U.S. and 608,570 people will die from the disease.
U.S. central venous catheter reaches a large vein through the internal femoral vein, subclavian vein, or jugular vein to administer fluids, medicines, blood, nutrients, and/or blood products. Catheters are made of medical grade material such as nylon, plastic, polyvinyl chloride (PVC), and silicon rubber, which are inserted in the body for therapeutic and diagnostic purposes. In short, a central venous catheter is easier and less painful than inserting a needle into a vein each time the patient needs medical attention.